Consulting Services
Compare Stocks
2 / 10Stock Comparison
EXPO vs FORR
Revenue, margins, valuation, and 5-year total return — side by side.
Consulting Services
EXPO vs FORR — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Consulting Services | Consulting Services |
| Market Cap | $3.12B | $125M |
| Revenue (TTM) | $582M | $397M |
| Net Income (TTM) | $106M | $-119M |
| Gross Margin | 40.1% | 64.6% |
| Operating Margin | 20.6% | -20.9% |
| Forward P/E | 30.9x | 8.5x |
| Total Debt | $83M | $72M |
| Cash & Equiv. | $222M | $63M |
EXPO vs FORR — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Exponent, Inc. (EXPO) | 100 | 85.5 | -14.5% |
| Forrester Research,… (FORR) | 100 | 20.8 | -79.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: EXPO vs FORR
Each card shows where this stock fits in a portfolio — not just who wins on paper.
EXPO carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 13 yrs, beta 0.89, yield 1.9%
- Rev growth 4.2%, EPS growth -1.9%, 3Y rev CAGR 4.3%
- 186.1% 10Y total return vs FORR's -75.9%
FORR is the clearest fit if your priority is defensive.
- Beta 0.68, current ratio 0.89x
- Lower P/E (8.5x vs 30.9x)
- Beta 0.68 vs EXPO's 0.89
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 4.2% revenue growth vs FORR's -8.2% | |
| Value | Lower P/E (8.5x vs 30.9x) | |
| Quality / Margins | 18.2% margin vs FORR's -30.1% | |
| Stability / Safety | Beta 0.68 vs EXPO's 0.89 | |
| Dividends | 1.9% yield; 13-year raise streak; the other pay no meaningful dividend | |
| Momentum (1Y) | -13.6% vs FORR's -35.7% | |
| Efficiency (ROA) | 13.7% ROA vs FORR's -28.2%, ROIC 36.3% vs 0.8% |
EXPO vs FORR — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
EXPO vs FORR — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
EXPO leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
EXPO and FORR operate at a comparable scale, with $582M and $397M in trailing revenue. EXPO is the more profitable business, keeping 18.2% of every revenue dollar as net income compared to FORR's -30.1%. On growth, EXPO holds the edge at +7.8% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $582M | $397M |
| EBITDAEarnings before interest/tax | $125M | -$66M |
| Net IncomeAfter-tax profit | $106M | -$119M |
| Free Cash FlowCash after capex | $122M | $18M |
| Gross MarginGross profit ÷ Revenue | +40.1% | +64.6% |
| Operating MarginEBIT ÷ Revenue | +20.6% | -20.9% |
| Net MarginNet income ÷ Revenue | +18.2% | -30.1% |
| FCF MarginFCF ÷ Revenue | +21.0% | +4.6% |
| Rev. Growth (YoY)Latest quarter vs prior year | +7.8% | -6.5% |
| EPS Growth (YoY)Latest quarter vs prior year | +6.5% | -79.1% |
Valuation Metrics
FORR leads this category, winning 6 of 6 comparable metrics.
Valuation Metrics
On an enterprise value basis, FORR's 8.0x EV/EBITDA is more attractive than EXPO's 23.0x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $3.1B | $125M |
| Enterprise ValueMkt cap + debt − cash | $3.0B | $134M |
| Trailing P/EPrice ÷ TTM EPS | 30.65x | -1.04x |
| Forward P/EPrice ÷ next-FY EPS est. | 30.87x | 8.54x |
| PEG RatioP/E ÷ EPS growth rate | 5.15x | — |
| EV / EBITDAEnterprise value multiple | 22.99x | 8.00x |
| Price / SalesMarket cap ÷ Revenue | 5.37x | 0.32x |
| Price / BookPrice ÷ Book value/share | 8.33x | 0.98x |
| Price / FCFMarket cap ÷ FCF | 25.54x | 6.92x |
Profitability & Efficiency
EXPO leads this category, winning 7 of 8 comparable metrics.
Profitability & Efficiency
EXPO delivers a 25.5% return on equity — every $100 of shareholder capital generates $26 in annual profit, vs $-81 for FORR. EXPO carries lower financial leverage with a 0.21x debt-to-equity ratio, signaling a more conservative balance sheet compared to FORR's 0.57x. On the Piotroski fundamental quality scale (0–9), EXPO scores 6/9 vs FORR's 4/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +25.5% | -80.8% |
| ROA (TTM)Return on assets | +13.7% | -28.2% |
| ROICReturn on invested capital | +36.3% | +0.8% |
| ROCEReturn on capital employed | +19.2% | +0.8% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 4 |
| Debt / EquityFinancial leverage | 0.21x | 0.57x |
| Net DebtTotal debt minus cash | -$139M | $9M |
| Cash & Equiv.Liquid assets | $222M | $63M |
| Total DebtShort + long-term debt | $83M | $72M |
| Interest CoverageEBIT ÷ Interest expense | — | -30.30x |
Total Returns (Dividends Reinvested)
EXPO leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in EXPO five years ago would be worth $7,147 today (with dividends reinvested), compared to $1,413 for FORR. Over the past 12 months, EXPO leads with a -13.6% total return vs FORR's -35.7%. The 3-year compound annual growth rate (CAGR) favors EXPO at -8.9% vs FORR's -36.6% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | -9.1% | -19.9% |
| 1-Year ReturnPast 12 months | -13.6% | -35.7% |
| 3-Year ReturnCumulative with dividends | -24.4% | -74.5% |
| 5-Year ReturnCumulative with dividends | -28.5% | -85.9% |
| 10-Year ReturnCumulative with dividends | +186.1% | -75.9% |
| CAGR (3Y)Annualised 3-year return | -8.9% | -36.6% |
Risk & Volatility
Evenly matched — EXPO and FORR each lead in 1 of 2 comparable metrics.
Risk & Volatility
FORR is the less volatile stock with a 0.68 beta — it tends to amplify market swings less than EXPO's 0.89 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. EXPO currently trades 77.4% from its 52-week high vs FORR's 56.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.89x | 0.68x |
| 52-Week HighHighest price in past year | $81.95 | $11.57 |
| 52-Week LowLowest price in past year | $63.25 | $4.88 |
| % of 52W HighCurrent price vs 52-week peak | +77.4% | +56.4% |
| RSI (14)Momentum oscillator 0–100 | 38.6 | 51.6 |
| Avg Volume (50D)Average daily shares traded | 452K | 109K |
Analyst Outlook
EXPO leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Wall Street rates EXPO as "Buy" and FORR as "Hold". EXPO is the only dividend payer here at 1.89% yield — a key consideration for income-focused portfolios.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold |
| Price TargetConsensus 12-month target | $85.00 | — |
| # AnalystsCovering analysts | 8 | 4 |
| Dividend YieldAnnual dividend ÷ price | +1.9% | — |
| Dividend StreakConsecutive years of raises | 13 | 6 |
| Dividend / ShareAnnual DPS | $1.20 | — |
| Buyback YieldShare repurchases ÷ mkt cap | +3.1% | +2.0% |
EXPO leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). FORR leads in 1 (Valuation Metrics). 1 tied.
EXPO vs FORR: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is EXPO or FORR a better buy right now?
For growth investors, Exponent, Inc.
(EXPO) is the stronger pick with 4. 2% revenue growth year-over-year, versus -8. 2% for Forrester Research, Inc. (FORR). Exponent, Inc. (EXPO) offers the better valuation at 30. 6x trailing P/E (30. 9x forward), making it the more compelling value choice. Analysts rate Exponent, Inc. (EXPO) a "Buy" — based on 8 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — EXPO or FORR?
On forward P/E, Forrester Research, Inc.
is actually cheaper at 8. 5x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — EXPO or FORR?
Over the past 5 years, Exponent, Inc.
(EXPO) delivered a total return of -28. 5%, compared to -85. 9% for Forrester Research, Inc. (FORR). Over 10 years, the gap is even starker: EXPO returned +186. 1% versus FORR's -75. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — EXPO or FORR?
By beta (market sensitivity over 5 years), Forrester Research, Inc.
(FORR) is the lower-risk stock at 0. 68β versus Exponent, Inc. 's 0. 89β — meaning EXPO is approximately 29% more volatile than FORR relative to the S&P 500. On balance sheet safety, Exponent, Inc. (EXPO) carries a lower debt/equity ratio of 21% versus 57% for Forrester Research, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — EXPO or FORR?
By revenue growth (latest reported year), Exponent, Inc.
(EXPO) is pulling ahead at 4. 2% versus -8. 2% for Forrester Research, Inc. (FORR). On earnings-per-share growth, the picture is similar: Exponent, Inc. grew EPS -1. 9% year-over-year, compared to -1993. 3% for Forrester Research, Inc.. Over a 3-year CAGR, EXPO leads at 4. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — EXPO or FORR?
Exponent, Inc.
(EXPO) is the more profitable company, earning 18. 2% net margin versus -30. 1% for Forrester Research, Inc. — meaning it keeps 18. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: EXPO leads at 20. 6% versus 0. 5% for FORR. At the gross margin level — before operating expenses — FORR leads at 53. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is EXPO or FORR more undervalued right now?
On forward earnings alone, Forrester Research, Inc.
(FORR) trades at 8. 5x forward P/E versus 30. 9x for Exponent, Inc. — 22. 3x cheaper on a one-year earnings basis.
08Which pays a better dividend — EXPO or FORR?
In this comparison, EXPO (1.
9% yield) pays a dividend. FORR does not pay a meaningful dividend and should not be held primarily for income.
09Is EXPO or FORR better for a retirement portfolio?
For long-horizon retirement investors, Exponent, Inc.
(EXPO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 89), 1. 9% yield, +186. 1% 10Y return). Both have compounded well over 10 years (EXPO: +186. 1%, FORR: -75. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between EXPO and FORR?
Both stocks operate in the Industrials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
EXPO pays a dividend while FORR does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.